These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 25269368)

  • 1. [Muscle-related adverse effects of statins].
    Pohjola-Sintonen S; Julkunen H
    Duodecim; 2014; 130(16):1622-7. PubMed ID: 25269368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil].
    Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L
    Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myotoxicity and rhabdomyolisis due to statins].
    Banga JD
    Ned Tijdschr Geneeskd; 2001 Dec; 145(49):2371-6. PubMed ID: 11770264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin-induced myopathy: the two faces of Janus.
    Arora R; Liebo M; Maldonado F
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):105-12. PubMed ID: 16891287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular complications of statins.
    Ahn SC
    Phys Med Rehabil Clin N Am; 2008 Feb; 19(1):47-59, vi. PubMed ID: 18194749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin-induced myopathy: a review and update.
    Abd TT; Jacobson TA
    Expert Opin Drug Saf; 2011 May; 10(3):373-87. PubMed ID: 21342078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.
    Harper CR; Jacobson TA
    Curr Opin Lipidol; 2007 Aug; 18(4):401-8. PubMed ID: 17620856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.
    Mohassel P; Mammen AL
    Muscle Nerve; 2013 Oct; 48(4):477-83. PubMed ID: 23519993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing statin myopathy.
    Venero CV; Thompson PD
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):121-36. PubMed ID: 19217515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
    Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
    Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes in 45 patients with statin-associated myopathy.
    Hansen KE; Hildebrand JP; Ferguson EE; Stein JH
    Arch Intern Med; 2005 Dec 12-26; 165(22):2671-6. PubMed ID: 16344427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin-induced myopathy.
    Gounden R; Blockman M
    Cardiovasc J Afr; 2008; 19(3):156-7. PubMed ID: 18568178
    [No Abstract]   [Full Text] [Related]  

  • 13. [Muscle problems due to statins: underestimated].
    Janssen SP; Smulders YM; Gerdes VE; Visseren FL
    Ned Tijdschr Geneeskd; 2010; 154():A1684. PubMed ID: 21435278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin myopathy as a metabolic muscle disease.
    Phillips PS; Haas RH
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):971-8. PubMed ID: 18666847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin-Associated Side Effects.
    Thompson PD; Panza G; Zaleski A; Taylor B
    J Am Coll Cardiol; 2016 May; 67(20):2395-2410. PubMed ID: 27199064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of aggressive statin therapy.
    Med Lett Drugs Ther; 2004 Nov; 46(1196):93-5. PubMed ID: 15557874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle toxicity with statins.
    Hedenmalm K; Alvan G; Ohagen P; Dahl ML
    Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):223-31. PubMed ID: 20014178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin myopathy: a common dilemma not reflected in clinical trials.
    Fernandez G; Spatz ES; Jablecki C; Phillips PS
    Cleve Clin J Med; 2011 Jun; 78(6):393-403. PubMed ID: 21632911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin-induced myopathies.
    Tomaszewski M; Stępień KM; Tomaszewska J; Czuczwar SJ
    Pharmacol Rep; 2011; 63(4):859-66. PubMed ID: 22001973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety considerations for statins.
    Bolego C; Baetta R; Bellosta S; Corsini A; Paoletti R
    Curr Opin Lipidol; 2002 Dec; 13(6):637-44. PubMed ID: 12441888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.